Comp.: | Study | Key Findings | Potential Limitation(s) |
---|---|---|---|
S1a | Donovan, J L/ 2016 [37] | Comparison: AS vs. RP vs. EBRT, follow-up timeb: 5-6 years, mean agec: 62 years - No significant differences were observed among intervention groups in measures of general health-related or cancer-related quality of life | |
S1 | Giberti, C/ 2009 [41] | Comparison: RP vs. BT, follow-up timeb: 5 years, mean agec: 65.3 years - No significant differences were observed among intervention groups in measures of general health-related or cancer-related quality of life | - Sample size <100 in both study arms - No intention to treat analyses |
S2 | Brundage, M/ 2015 [36] | Comparison: ADT vs. ADT + EBRT, follow-up timeb: 5-8 years, median agec: 69.7 years - No significant between-arm differences in physical or role functioning at any time point 5+ years after diagnosis - Significant (p < 0.001) deterioration in both arms over time for physical and role functioning | - Sample size <100 in both study arms - Only results on physical and role functioning were reported for this follow-up time |